UNII,MainDrug,NDC,Strength,Formulation,INGREDIENT_NAME,ROUTE,DOSAGE_FORM,CAS_NUMBER,POTENCY_AMOUNT,POTENCY_UNIT,MAXIMUM_DAILY_EXPOSURE,MAXIMUM_DAILY_EXPOSURE_UNIT,RECORD_UPDATED
7T1F30V5YH,trastuzumab,50242-077,10000 U  in 5 mL," and hyaluronidase-oysk injection, solution",POLYSORBATE 20,INTRAVENOUS,"INJECTION, POWDER, FOR SOLUTION",9005645.0,,,,,
7T1F30V5YH,trastuzumab,50242-077,10000 U  in 5 mL," and hyaluronidase-oysk injection, solution",POLYSORBATE 20,INTRAVENOUS,"INJECTION, POWDER, FOR SOLUTION",9005645.0,,,,,
7T1F30V5YH,trastuzumab,50242-132,150 mg  in 7.4 mL," injection, powder, lyophilized, for solution",POLYSORBATE 20,INTRAVENOUS,"INJECTION, POWDER, FOR SOLUTION",9005645.0,,,,,
